The GPR40 novel agonist SZZ15‐11 improves non‐alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet‐induced obese mice
Article in Diabetes Obesity and Metabolism (March 2024)
The most recent citing publications are shown below. View all 124 publications that cite this research output on Dimensions.
The role of G protein-coupled receptors and receptor kinases in pancreatic β-cell function and diabetes
Article in Pharmacological Reviews (January 2024)
Evolution of the Synthetic Process to an Advanced GPR40 Agonist
Article in Organic Process Research & Development (January 2024)